Carlos Cordon-Cardo

Carlos Cordon-Cardo

Department of Pathology, Icahn School of Medicine at Mount Sinai

Affiliated withIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai

Research Area

Biography

Carlos Cordon-Cardo has not added Biography.
If you are Carlos Cordon-Cardo and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 4
Year
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Publication title

Cited by 6

2014
2015
2017
2019

Other Publications

Article
Year
Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Science (New York, N.Y.)| PubMed ID: 12750523

2003
Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas.

Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry| PubMed ID: 12777996

2003
2003
Oncogenes in melanoma.

Oncogene| PubMed ID: 12789285

2003
2003
Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 12855638

2003
Gene discovery in bladder cancer progression using cDNA microarrays.

The American journal of pathology| PubMed ID: 12875971

2003
2003
2003
Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc| PubMed ID: 12920217

2003
2003
2003
p73alpha regulation by Chk1 in response to DNA damage.

Molecular and cellular biology| PubMed ID: 14585975

2003
2004
2003
2003
p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 14654547

2003
2003
MDM2 and prognosis.

Molecular cancer research : MCR| PubMed ID: 14757840

2004
Loss of the tumor suppressor PML in human cancers of multiple histologic origins.

Journal of the National Cancer Institute| PubMed ID: 14970276

2004
2004
p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 14981108

2004
2004
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology| PubMed ID: 15006913

2004
Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15014038

2004
2004
2004
2004
High-resolution characterization of the pancreatic adenocarcinoma genome.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 15199222

2004
2004
Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc| PubMed ID: 15257316

2004
2004
2004
2004
2004
2004
Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression.

Diagnostic molecular pathology : the American journal of surgical pathology, part B| PubMed ID: 15538112

2004
2004
Racial disparity of epidermal growth factor receptor expression in prostate cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 15570072

2004
Role of Dok-1 and Dok-2 in leukemia suppression.

The Journal of experimental medicine| PubMed ID: 15611295

2004
2004
Molecular profiling of tumor progression in head and neck cancer.

Archives of otolaryngology--head & neck surgery| PubMed ID: 15655179

2005
2005
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer.

Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry| PubMed ID: 15722787

2005
Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15756026

2005
2005
Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15867226

2005
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15897584

2005
2005
2005
2005
2005
Expression of p63 in diffuse large B-cell lymphoma.

Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry| PubMed ID: 16082248

2005
2005
2005
2005
2005
2005
2005
A novel logistic model based on clinicopathological features predicts microsatellite instability in colorectal carcinomas.

Diagnostic molecular pathology : the American journal of surgical pathology, part B| PubMed ID: 16319691

2005
[Molecular protocol for HER2/neu analysis in breast carcinoma].

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico| PubMed ID: 16373062

2005
Differential exoprotease activities confer tumor-specific serum peptidome patterns.

The Journal of clinical investigation| PubMed ID: 16395409

2006
Profiling bladder cancer using targeted antibody arrays.

The American journal of pathology| PubMed ID: 16400012

2006
Amplification of CDK4 and MDM2 in malignant melanoma.

Genes, chromosomes & cancer| PubMed ID: 16419059

2006
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 16432078

2006
2006
2006
Autocrine PDGFR signaling promotes mammary cancer metastasis.

The Journal of clinical investigation| PubMed ID: 16741576

2006
2006
2006
2006
2006
2006
2006
2006
2006
2007
Technology insight: will systems pathology replace the pathologist?

Nature clinical practice. Urology| PubMed ID: 17211424

2007
2007
2007
2007
2007
2007
Role of the chromobox protein CBX7 in lymphomagenesis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17374722

2007
2007
2007
A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 17545525

2007
2007
Improved prediction of prostate cancer recurrence through systems pathology.

The Journal of clinical investigation| PubMed ID: 17557117

2007
2007
Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 17671137

2007
2007
2007
Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17921246

2007
2007
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.

The Journal of clinical investigation| PubMed ID: 17948129

2007
2011
2007
2008
A context dependent role for Wnt signaling in tumorigenesis and stem cells.

Cell cycle (Georgetown, Tex.)| PubMed ID: 18239459

2008
TREK-1 is a novel molecular target in prostate cancer.

Cancer research| PubMed ID: 18281496

2008
2008
2008
2008
2008
2008
Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 18711180

2008
2008
Molecular alterations associated with bladder cancer initiation and progression.

Scandinavian journal of urology and nephrology. Supplementum| PubMed ID: 18815930

2008
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology| PubMed ID: 18990762

2008
2009
2009
2008
Identification of PMF1 methylation in association with bladder cancer progression.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19088041

2008
2009
2009
2009
2009
2009
2009
2009
Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19435838

2009
2009
2009
2009
2009
2010
2009
2009
2009
Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 20008839

2010
miR-19 is a key oncogenic component of mir-17-92.

Genes & development| PubMed ID: 20008935

2009
Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers.

International journal of cancer. Journal international du cancer| PubMed ID: 20112337

2010
PHF6 mutations in T-cell acute lymphoblastic leukemia.

Nature genetics| PubMed ID: 20228800

2010
2010
Galectin-3 expression is associated with bladder cancer progression and clinical outcome.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine| PubMed ID: 20401558

2010
2010
2010
2010
2010
2010
2010
2011
2011
2011
2012
2011
Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico| PubMed ID: 21421465

2011
2011
2012
2012
2012
A Role for PML in Innate Immunity.

Genes & cancer| PubMed ID: 21779477

2011
2011
Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool.

Acta cirúrgica brasileira / Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia| PubMed ID: 22030824

2011
Personalized approach to prostate cancer prognosis.

Archivos españoles de urología| PubMed ID: 22052759

2011
2012
Mouse models of human bladder cancer as a tool for drug discovery.

Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.]| PubMed ID: 22294368

2010
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico| PubMed ID: 22374423

2012
2012
2012
Translocation renal cell carcinomas in adults: a single-institution experience.

The American journal of surgical pathology| PubMed ID: 22446944

2012
2012
2012
2012
2012
2012
2013
Predicting high-risk disease using tissue biomarkers.

Current opinion in urology| PubMed ID: 23478499

2013
2012
2013
2013
2013
2013
2013
2014
2014
2014
2014
FBXW7 mutations in melanoma and a new therapeutic paradigm.

Journal of the National Cancer Institute| PubMed ID: 24838835

2014
2014
2014
2014
2014
Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers.

Expert review of molecular diagnostics| PubMed ID: 25327491

2014
Biomarkers for bladder cancer management: present and future.

American journal of clinical and experimental urology| PubMed ID: 25374904

2014
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2015
2016
Immunopathologic Assessment of PTEN Expression.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 27033068

2016
2016
2016
2016
2016
2016
The role of GATA2 in lethal prostate cancer aggressiveness.

Nature reviews. Urology| PubMed ID: 27872477

2017
2017
2017
2017
2017
2017
2017
2017
2017
2017